0
Abstract: Poster Presentations |

ENDOBRONCHIAL CHEMOTHERAPY IN MALIGNANT LUNG LESIONS REPORT OF 3 YEARS EXPERIENCE FREE TO VIEW

HamidReza Jabbardarjani, MD*; Hasan Safara, MD; Shahram Kharabian, MD; Mohammad Reza Masjedi, MD
Author and Funding Information

National Research Institute of Tuberculosis and Lung Disease, Tehran, Iran


Chest


Chest. 2007;132(4_MeetingAbstracts):519c-520. doi:10.1378/chest.132.4_MeetingAbstracts.519c
Text Size: A A A
Published online

Abstract

PURPOSE: Our interest in this study is to present our experience about the efficacy of Intrabronchial Chemotherapy in palliative care and survival of patients with inoperable Lung Cancers.

METHODS: : Fifty patients were studied (36 men, 14 women). All of them diagnosed with inoperable lung cancer. According to the histologic report they were categorized to 3 groups of, Adenocarcinoma (48%), Squamous cell carcinoma (32%), Non Small Cell Lung Cancer, unspecified (20%). Initial symptoms included, dyspnea (94%), cough (90%), sputum (80%), non massive hemoptysis (68%), fever and chills (56%), massive Hemoptysis (4%), chest pain (66%). All of the procedures performed via Olympus BF type 200 videobronchoscope. Cisplatin with the concentration of 50 mg/100 cc was used for all the cases as the chemotherapeutic solution. Maximum Four mg cisplatin per cm2 of tumor mass was injected intratumorally (Totally 20 cc). These procedures were performed weekly for 4 times. If patient didn’t have Radiotherapy indication this procedure performed Monthly.

RESULTS: At the end of the 4 th session of local chemotherapy, symptoms relief was seen in 52% of patients. Average survival time in the worst condition was 3 months and in the best condition was 15 months.

CONCLUSION: We strongly suggest Endobronchial Chemotherapy with cisplatin in palliation of inoperable Endobronchial malignant lesion.

CLINICAL IMPLICATIONS: There was no complication in our study.

DISCLOSURE: HamidReza Jabbardarjani, None.

Wednesday, October 24, 2007

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543